Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Biomaterials|April 23, 2013
Selective photocrosslinking of functional ligands to antibodies via the conserved nucleotide binding siteNathan J Alves, Matthew M Champion, Jared F Stefanick, et al.
JCO Oncology Practice|December 5, 2019
Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute CareRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
The Lancet. Oncology|August 15, 2015
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trialsBernardo L Rapoport, Martin R Chasen, Cesare Gridelli, et al.
Future Oncology (London, England)|March 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugatesYeon Hee Park, Giampaolo Bianchini, Javier Cortés, et al.
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxisLee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, et al.
Journal of Geriatric Oncology|April 22, 2019
Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE)Grant R Williams, Kelly M Kenzik, Mariel Parman, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Cancer|July 13, 2002
Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869Simon Van Belle, Michael R Lichinitser, Rudolph M Navari, et al.
Pageof 8